comparemela.com

Latest Breaking News On - Month results from - Page 3 : comparemela.com

VIVA Foundation Symposium presents Clinical Trial Findings

The second round of late-breaking clinical trial results were presented at VIVA22 on Nov. 1 in Las Vegas, NV.

Thomas maldonadoPetera soukasMichael lichtenbergIdo weinbergDaniel clairPrakash krishnanLas vegasPenumbra incGore associatesLimflow incSociety for vascular surgeryVascular interventional advancesYear resultsSuperficial femoral arterySingle arm studyPatient reported quality

Late-breaking Clinical Trial presentations announced for The VEINS and VIVA Conference

Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA (Vascular InterVentional Advances) Annual Conference have been announced. Leading physicians and researchers will present results from 21 clinical trials, from Monday, October 31, to Wednesday, November 2, at Wynn Las Vegas.

Kenneth rosenfieldWynn las vegasElias iliadisTjun tangSean lydenChristopher kwolekThomas maldonadoMichael lichtenbergIdo weinbergPrakash krishnanSurendra shenoyDavid dexterDaniel bertgesEhrin armstrongJohn filtesSteven abramowitz

First-on-Podium Data from 21 Vascular Interventional Clinical Trials to Be Presented at The VEINS and VIVA 2022

/PRNewswire/ Leading physicians and researchers will present results from 21 clinical trials from Monday, October 31, to Wednesday, November 2, at the.

Kenneth rosenfieldWynn las vegasElias iliadisTjun tangSean lydenChristopher kwolekThomas maldonadoMichael lichtenbergIdo weinbergPrakash krishnanSurendra shenoyDavid dexterDaniel bertgesEhrin armstrongJohn filtesSteven abramowitz

Clinical Data Presented at American Diabetes Association 82nd Scientific Sessions Reinforce Significant and Durable Benefits of Nevro s HFX 10 kHz Therapy

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

United statesRedwood cityGeorge grunbergerErika petersenJulie deweyTrinity partners market researchWorld health organizationNevro corpNational diabetes statisticsExchange commissionUniversity of arkansasGrunberger diabetes instituteCorp communicationsMonth resultsTreating painful diabetic neuropathyScientific sessions

Nevro Announces SENZA-PDN Clinical Data Presentations at the American Diabetes Association 82nd Scientific Sessions

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

United statesRedwood cityErika petersenGeorge grunbergerJulie deweyTrinity partners market researchNevro corpWorld health organizationAmerican diabetes associationPrnewswire nevro corpNational diabetes statisticsExchange commissionAmerican diabetes association scientific sessionsCompany toCorp communicationsPoster presentation

vimarsana © 2020. All Rights Reserved.